Authors: Becouarn, Y Gamelin, E Coudert, B Negrier, S Pierga, JY Raoul, JL Provencal, J Rixe, O Krisch, C Germa, C Bekradda, M Mignard, D Mousseau, M

Citation: Y. Becouarn et al., Randomized multicenter phase II study comparing a combination of fluorouracil and folinic acid and alternating irinotecan and oxaliplatin with oxaliplatin and irinotecan in fluorouracil-pretreated metastatic colorectal cancer patients, J CL ONCOL, 19(22), 2001, pp. 4195-4201

Authors: Ducreux, N Fizazi, K Seitz, JF Becouarn, Y Armand, JP

Citation: N. Ducreux et al., Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer, B CANCER, 88, 2001, pp. S35-S39

Authors: Becouarn, Y Blanc-Vincent, MP Ducreux, M Lasser, P Dubois, JB Giovannini, M Rougier, P

Citation: Y. Becouarn et al., Cancer of the rectum, BR J CANC, 84, 2001, pp. 69-73

Authors: Henry, B Becouarn, Y Aussage, P

Citation: B. Henry et al., Clinical benefits of stabilisation with second line chemotherapy in patients with metastatic colorectal cancer, CR R ONC H, 32(2), 1999, pp. 145-154

Authors: Becouarn, Y

Citation: Y. Becouarn, Standards, options and guidelines for management of patients with primary adenocarcinoma of the tectum, PRESSE MED, 28(25), 1999, pp. 1367-1374

Authors: Henry-Launois, B Becouarn, Y Aussage, P

Citation: B. Henry-launois et al., Clinical benefits of stabilization after second-line chemotherapy in patients with metastatic colorectal cancer, B CANCER, 86(2), 1999, pp. 195-201